32 related articles for article (PubMed ID: 10649730)
1. Infusion of total dose iron versus oral iron supplementation in ambulatory peritoneal dialysis patients: a prospective, cross-over trial.
Ahsan N
Adv Perit Dial; 2000; 16():80-4. PubMed ID: 11045266
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
[TBL] [Abstract][Full Text] [Related]
3. Importance of iron saturation for erythropoietin responsiveness in chronic peritoneal dialysis.
Jonnalagadda V; Bloom EJ; Raja RM
Adv Perit Dial; 1997; 13():113-5. PubMed ID: 9360662
[TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: a single center comparative study.
Ahsan N
J Am Soc Nephrol; 1998 Apr; 9(4):664-8. PubMed ID: 9555669
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
[TBL] [Abstract][Full Text] [Related]
6. ITDI is the preferred treatment for iron supplementation in rHuEpo-treated anemic PD patients.
Ahsan N
Adv Perit Dial; 1998; 14():228-31. PubMed ID: 10649730
[TBL] [Abstract][Full Text] [Related]
7. Iron supplementation in renal anemia.
Fishbane S
Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
[TBL] [Abstract][Full Text] [Related]
8. The treatment of anemia in peritoneal dialysis patients.
Lacson E; Diaz-Buxo JA
Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
Tarng DC; Huang TP; Chen TW; Yang WC
Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
[TBL] [Abstract][Full Text] [Related]
10. Appropriate hematocrit levels of erythropoietin supplementary therapy in end-stage renal failure complicated by coronary artery disease.
Nagao K; Tsuchihashi K; Ura N; Nakata T; Shimamoto K
Can J Cardiol; 1997 Aug; 13(8):747-53. PubMed ID: 9284841
[TBL] [Abstract][Full Text] [Related]
11. Role of iron in optimizing responses of anemic cancer patients to erythropoietin.
Glaspy J; Cavill I
Oncology (Williston Park); 1999 Apr; 13(4):461-73; discussion 477-8, 483-8. PubMed ID: 10234700
[TBL] [Abstract][Full Text] [Related]
12. [Anemia and its treatment in peritoneal dialysis patients].
Hörl WH
Wien Klin Wochenschr; 2005; 117 Suppl 6():69-72. PubMed ID: 16437336
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
